N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen

C86H91N19O4 — CID 157304261

About N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen

N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen (PubChem CID 157304261) has the molecular formula C86H91N19O4 and a molecular weight of 1454.80 g/mol. Its IUPAC name is N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen.

Molecular Properties

• Compound Name: N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen
• PubChem CID: 157304261
• Molecular Formula: C86H91N19O4
• Molecular Weight: 1454.80 g/mol
• Exact Mass: 1453.75
• IUPAC Name: N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen
• SMILES: C=C(c1ccc(-c2cnc(C)c(-c3nnc(NCc4ccccc4)o3)n2)cc1)N(C)C.CCc1ccccc1-c1cnc(C)c(-c2nnc(-c3ccccc3)o2)n1.Cc1ncc(-c2ccccc2C(C)C)nc1-c1nnc(-c2ccccc2)o1.Cc1ncc(-c2ccccc2N)nc1-c1nnc(-c2ccccc2)o1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
• InChI: InChI=1S/C24H24N6O.C22H20N4O.C21H18N4O.C19H15N5O.7H2/c1-16-22(23-28-29-24(31-23)26-14-18-8-6-5-7-9-18)27-21(15-25-16)20-12-10-19(11-13-20)17(2)30(3)4;1-14(2)17-11-7-8-12-18(17)19-13-23-15(3)20(24-19)22-26-25-21(27-22)16-9-5-4-6-10-16;1-3-15-9-7-8-12-17(15)18-13-22-14(2)19(23-18)21-25-24-20(26-21)16-10-5-4-6-11-16;1-12-17(19-24-23-18(25-19)13-7-3-2-4-8-13)22-16(11-21-12)14-9-5-6-10-15(14)20;;;;;;;/h5-13,15H,2,14H2,1,3-4H3,(H,26,29);4-14H,1-3H3;4-13H,3H2,1-2H3;2-11H,20H2,1H3;7*1H
• InChIKey: BCGNNSYVDMFFFW-UHFFFAOYSA-N
• XLogP: 20.14
• TPSA: 300.09 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 23
• Rotatable Bonds: 18
• Heavy Atoms: 109
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1454.80
LogP ≤ 5	20.14
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	23

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aniline', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen?

The IUPAC name of N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen (CID 157304261) is N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen.

What is the SMILES notation for N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen?

The canonical SMILES for N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen is C=C(c1ccc(-c2cnc(C)c(-c3nnc(NCc4ccccc4)o3)n2)cc1)N(C)C.CCc1ccccc1-c1cnc(C)c(-c2nnc(-c3ccccc3)o2)n1.Cc1ncc(-c2ccccc2C(C)C)nc1-c1nnc(-c2ccccc2)o1.Cc1ncc(-c2ccccc2N)nc1-c1nnc(-c2ccccc2)o1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].

What is the InChIKey of N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen?

The InChIKey is BCGNNSYVDMFFFW-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H24N6O.C22H20N4O.C21H18N4O.C19H15N5O.7H2/c1-16-22(23-28-29-24(31-23)26-14-18-8-6-5-7-9-18)27-21(15-25-16)20-12-10-19(11-13-20)17(2)30(3)4;1-14(2)17-11-7-8-12-18(17)19-13-23-15(3)20(24-19)22-26-25-21(27-22)16-9-5-4-6-10-16;1-3-15-9-7-8-12-17(15)18-13-22-14(2)19(23-18)21-25-24-20(26-21)16-10-5-4-6-11-16;1-12-17(19-24-23-18(25-19)13-7-3-2-4-8-13)22-16(11-21-12)14-9-5-6-10-15(14)20;;;;;;;/h5-13,15H,2,14H2,1,3-4H3,(H,26,29);4-14H,1-3H3;4-13H,3H2,1-2H3;2-11H,20H2,1H3;7*1H.

What are the key properties of N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen?

N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen has a molecular weight of 1454.80 g/mol, XLogP of 20.14, 18 rotatable bonds, 2 hydrogen bond donors, and 23 hydrogen bond acceptors.

Where does this data come from?

All data for N-benzyl-5-[6-[4-[1-(dimethylamino)ethenyl]phenyl]-3-methylpyrazin-2-yl]-1,3,4-oxadiazol-2-amine;2-[6-(2-ethylphenyl)-3-methylpyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;2-[5-methyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]aniline;2-[3-methyl-6-(2-propan-2-ylphenyl)pyrazin-2-yl]-5-phenyl-1,3,4-oxadiazole;molecular hydrogen is sourced from PubChem (CID 157304261), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).